A predictive model of overall survival in patients with metastatic castration-resistant prostate cancer

Metastatic castration resistant prostate cancer (mCRPC) is one of the most common cancers with a poor prognosis. To improve prognostic models of mCRPC, the Dialogue for Reverse Engineering Assessments and Methods (DREAM) Consortium organized a crowdsourced competition known as the Prostate Cancer DR...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:F1000Res
Main Authors: Mahmoudian, Mehrad, Seyednasrollah, Fatemeh, Koivu, Liisa, Hirvonen, Outi, Jyrkkiö, Sirkku, Elo, Laura L.
Format: Artigo
Jezik:Inglês
Izdano: F1000 Research Limited 2019
Teme:
Method Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6556990/
https://ncbi.nlm.nih.gov/pubmed/31231503
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.8192.2
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki